Generalized description of the spatio-temporal biphoton State in spontaneous parametric down-conversion

Spontaneous parametric down-conversion (SPDC) is a widely used source for photonic entanglement. Years of focused research have led to a solid understanding of the process, but a cohesive analytical description of the paraxial biphoton state has yet to be achieved. We derive a general expression for the spatio-temporal biphoton state that applies universally across common experimental settings and correctly describes the non-separability of spatial and spectral modes. We formulate a criterion on how to decrease the coupling of the spatial from the spectral degree of freedom by taking into account the Gouy phase of interacting beams. This work provides new insights into the role of the Gouy phase in SPDC, and also into the preparation of engineered entangled states for multidimensional quantum information processing

Software para diseño de vigas aperaltadas de concreto reforzado aplicando el modelo puntal-tensor según, ACI 318-14.

Esta tesis explica sobre el modelo puntal - tensor para el diseño de otros elementos estructurales de concreto reforzado. Software, herramienta eficiente para el diseño estructural. Se aborda todos los fundamentos acerca de la aplicación del modelo puntal - tensor en las estructuras. Software STD

EVALUACIÓN DE LA RESISTENCIA AL DESGASTE ABRASIVO EN RECUBRIMIENTOS DUROS PARA APLICACIONES EN LA INDUSTRIA MINERA

Fue estudiada la resistencia al desgaste abrasivo de dos recubrimientos duros de alto Cr y alto W, usados como protección en la industria minera. Los recubrimientos fueron aplicados en una sola capa sobre un substrato de acero estructural AISI A36, mediante soldadura eléctrica SMAW. El recubrimiento RFeCrA1, aplicado con soldadura oxiacetilénica, fue usado como material de comparación debido a su elevada resistencia a la abrasión. La resistencia al desgaste se evaluó en máquina de arena seca y rueda de caucho mediante el procedimiento A de la norma ASTM G65. Las superficies desgastadas fueron analizadas con ayuda de microscopía óptica y electrónica. Los resultados mostraron que la mayor resistencia al desgaste abrasivo se obtuvo con recubrimientos cuya microestructura está compuesta por carburos primarios de tipo (Fe,Cr)7C3 y matriz eutéctica, mientras que en muestras donde se observó austenita pro-eutéctica la pérdida de masa fue mayor. El recubrimientos tipo Fe-W-C, en cuya microestructura se observaron carburos de tipo WC, presentó también elevada resistencia al desgaste debido a la dureza y capacidad de deformación de la estructura

Reduced L-carnitine transport in aortic endothelial cells from spontaneously hypertensive rats

Impaired L-carnitine uptake correlates with higher blood pressure in adult men, and L-carnitine restores endothelial function in aortic rings from spontaneously hypertensive rat (SHR). Thus, endothelial dysfunction in hypertension could result from lower L-carnitine transport in this cell type. L-Carnitine transport is mainly mediated by novel organic cation transporters 1 (Octn1, Na+-independent) and 2 (Octn2, Na+-dependent); however, their kinetic properties and potential consequences in hypertension are unknown. We hypothesize that L-carnitine transport kinetic properties will be altered in aortic endothelium from spontaneously hypertensive rats (SHR). L-Carnitine transport was measured at different extracellular pH (pHo 5.5–8.5) in the absence or presence of sodium in rat aortic endothelial cells (RAECs) from non-hypertensive Wistar-Kyoto (WKY) rats and SHR. Octn1 and Octn2 mRNA relative expression was also determined. Dilation of endothelium-intact or denuded aortic rings in response to calcitonine gene related peptide (CGRP, 0.1–100 nmol/L) was measured (myography) in the absence or presence of L-carnitine. Total L-carnitine transport was lower in cells from SHR compared with WKY rats, an effect due to reduced Na+-dependent (Na+dep) compared with Na+-independent (Na+indep) transport components. Saturable L-carnitine transport kinetics show maximal velocity (Vmax), without changes in apparent Km for Na+indep transport in SHR compared with WKY rats. Total and Na+dep component of transport were increased, but Na+indep transport was reduced by extracellular alkalization in WKY rats. However, alkalization reduced total and Na+indep transport in cells from SHR. Octn2 mRNA was higher than Octn-1 mRNA expression in cells from both conditions. Dilation of artery rings in response to CGRP was reduced in vessels from SHR compared with WKY rats. CGRP effect was endothelium-dependent and restored by L-carnitine. All together these results suggest that reduced L-carnitine transport (likely via Na+-dependent Octn2) could limit this compound's potential beneficial effects in RAECs from SHR

Phylogenomic Analysis of the Plastid Genome of the Peruvian Purple Maize Zea mays subsp. mays cv. ‘INIA 601’

Peru is an important center of diversity for maize; its different cultivars have been adapted to distinct altitudes and water availability and possess an array of kernel colors (red, blue, and purple), which are highly appreciated by local populations. Specifically, Peruvian purple maize is a collection of native landraces selected and maintained by indigenous cultures due to its intense purple color in the seed, bract, and cob. This color is produced by anthocyanin pigments, which have gained interest due to their potential use in the food, agriculture, and pharmaceutical industry. It is generally accepted that the Peruvian purple maize originated from a single ancestral landrace ‘Kculli’, but it is not well understood. To study the origin of the Peruvian purple maize, we assembled the plastid genomes of the new cultivar ‘INIA 601’ with a high concentration of anthocyanins, comparing them with 27 cultivars/landraces of South America, 9 Z. mays subsp. parviglumis, and 5 partial genomes of Z. mays subsp. mexicana. Using these genomes, plus four other maize genomes and two outgroups from the NCBI database, we reconstructed the phylogenetic relationship of Z. mays. Our results suggest a polyphyletic origin of purple maize in South America and agree with a complex scenario of domestication with recurrent gene flow from wild relatives. Additionally, we identify 18 plastid positions that can be used as high-confidence genetic markers for further studies. Altogether, these plastid genomes constitute a valuable resource to study the evolution and domestication of Z. mays in South America

Clinical characteristics and outcomes of thymoma-associated myasthenia gravis

[Background and purpose] Prognosis of myasthenia gravis (MG) in patients with thymoma is not well established. Moreover, it is not clear whether thymoma recurrence or unresectable lesions entail a worse prognosis of MG.[Methods] This multicenter study was based on data from a Spanish neurologist-driven MG registry. All patients were aged >18 years at onset and had anti-acetylcholine receptor antibodies. We compared the clinical data of thymomatous and nonthymomatous patients. Prognosis of patients with recurrent or nonresectable thymomas was assessed.[Results] We included 964 patients from 15 hospitals; 148 (15.4%) had thymoma-associated MG. Median follow-up time was 4.6 years. At onset, thymoma-associated MG patients were younger (52.0 vs. 60.4 years, p < 0.001), had more generalized symptoms (odds ratio [OR]: 3.02, 95% confidence interval [CI]: 1.95–4.68, p < 0.001) and more severe clinical forms according to the Myasthenia Gravis Foundation of America (MGFA) scale (OR: 1.6, 95% CI: 1.15–2.21, p = 0.005). Disease severity based on MGFA postintervention status (MGFA-PIS) was higher in thymomatous patients at 1 year, 5 years, and the end of follow-up. Treatment refractoriness and mortality were also higher (OR: 2.28, 95% CI: 1.43–3.63, p = 0.001; hazard ratio: 2.46, 95% CI: 1.47–4.14, p = 0.001). Myasthenic symptoms worsened in 13 of 27 patients with recurrences, but differences in long-term severity were not significant. Fifteen thymomatous patients had nonresectable thymomas with worse MGFA-PIS and higher mortality at the end of follow-up.[Conclusions] Thymoma-associated MG patients had more severe myasthenic symptoms and worse prognosis. Thymoma recurrence was frequently associated with transient worsening of MG, but long-term prognosis did not differ from nonrecurrent thymoma. Patients with nonresectable thymoma tended to present severe forms of MG.This work is supported by Fondo de Investigaciones Sanitarias (FIS) grant FIS19/01774, Instituto de Salud Carlos III and cofunded by the European Union (ERDF/ESF, A Way to Make Europe/Investing in Your Future). Rodrigo Álvarez-Velasco was supported by a PhD for Medical Doctors grant from the Pla Estratègic de Recerca i Innovació en Salut (PERIS), Generalitat de Catalunya (SLT008/18/00207). Elena Cortés-Vicente was supported by a Juan Rodés grant (JR19/00037) from the Fondo de Investigación en Salud, Instituto de Salud Carlos III, Ministry of Health (Spain).Peer reviewe

Drug-refractory myasthenia gravis : Clinical characteristics, treatments, and outcome

Altres ajuts: R. Alvarez-Velasco was supported by grant SLT008/18/00207 from the Health Research and Innovation Strategic Plan (PERIS). The NMD-ES Project and F. PlaJunca (data curator) are partially funded by the Centro de Investigacion Biomédica en Red de Enfermedades Raras (CIBERER).To describe the clinical characteristics and outcomes in patients with refractory myasthenia gravis (MG) and to determine the effectiveness and side effects of the drugs used for their treatment. This observational retrospective cross-sectional multicenter study was based on data from the Spanish MG Registry (NMD-ES). Patients were considered refractory when their MG Foundation of America post-interventional status (MGFA-PIS) was unchanged or worse after corticosteroids and two or more other immunosuppressive agents. Clinical and immunologic characteristics of drug-refractory patients, efficiency and toxicity of drugs used, and outcome (MGFA-PIS) at end of follow-up were studied. We included 990 patients from 15 hospitals. Eighty-four patients (68 of 842 anti-acetylcholine receptor [AChR], 5 of 26 anti-muscle-specific tyrosine kinase [MusK], 10 of 120 seronegative, and 1 of 2 double-seropositive patients) were drug refractory. Drug-refractory patients were more frequently women (p < 0.0001), younger at onset (p < 0.0001), and anti-MuSK positive (p = 0.037). Moreover, they more frequently presented a generalized form of the disease, bulbar symptoms, and life-threatening events (p < 0.0001; p = 0.018; and p = 0.002, respectively) than non-drug-refractory patients. Mean follow-up was 9.8 years (SD 4.5). Twenty-four (50%) refractory patients had side effects to one or more of the drugs. At the end of follow-up, 42.9% of drug-refractory patients (42.6% of anti-AChR, 100% of anti-MuSK, and 10% of seronegative patients) and 79.8% of non-drug-refractory patients (p < 0.0001) achieved remission or had minimal manifestations. Eighty percent of drug-refractory-seronegative patients did not respond to any drug tested. In this study, 8.5% of MG patients were drug-refractory. New more specific drugs are needed to treat drug-refractory MG patients

Detección proviral de HTLV-1 mediante reacción en cadena de la polimerasa (PCR)

Objetivos: Detectar el genoma proviral de HTLV-1 mediante el desarrollo de reacción en cadena de la polimerasa (PCR). Diseño: Descriptivo. Institución: D.A. Microbiología Médica, Facultad de Medicina, UNMSM. Participantes: Personas con y sin sospecha de HTLV-I. Principales medidas de resultados: detección de HTLV-1 mediante PCR. Resultados: El 71,4% de los pacientes con sospecha clínica de HTLV-I fue reactivo por métodos Inmunológico. Elisa HTLV I-II Biokit detectó 5 casos reactivos (X=2,359 ± DE: 0,7309); los dos casos con sospecha clínica de HTLV- I fueron no reactivos (DO: 0,007 y 0,04); los tres casos con antecedente clínico de estrongiloidiosis fueron no reactivos al Elisa (DO: 0,029, 0,001 y 0,00). El promedio de los sueros no reactivos con antecedente clínico de HTLV-1 y estrongiloidiosis fue 0,0154 ±0,018. En el grupo de voluntarios sanos, el promedio de las DO fue 0,0085 ± 0,0068. Al comparar los grupos, se observó que hubo diferencias significativas entre el grupo HTLV-1 y los grupos estrongiloidiosis y controles sanos (p&lt;0,05). La amplificación del ADN gonómico (proviral) de muestras sanguíneas utilizó primers de la región Pol I. Conclusiones: El método inmunológico permitió diferenciar los grupos de estudio. El producto de amplificación de los pacientes con HTLV-I fue de 117 pb